Navigation Links
Lean Protein Could Be Key to Obesity Drugs,,

A protein that lets mice eat more but weigh less could prove the magic ingredient for diet drugs of the future.British scientists from drug giant SmithKline Beecham and the University of Cambridge have created mice with a human protein known as Uncoupling Protein 3 (UCP3) that increases their metabolism.In what is every dieter's dream, the mice were able to eat more than normal mice but still weigh less.

"Extra UCP3 increases metabolic rate. The effect it has is to increase fat combustion, so the animals are burning more fat," Dr John Clapham, of SmithKline Beecham, said."They eat more because they have a higher metabolic rate but it is true they eat more and weigh less."

Like exercise, the excess UCP3 causes the mice to burn more fat but without the pain, sweat and hard work."In a research study published in the science journal Nature, Clapham and his team showed that even though the transgenic mice ate 15-54 percent more food than normal mice, their fat-tissue mass was 44-57 percent less.The mice experienced no side effects from the increased UCP3. They had 70 percent lower cholesterol levels than normal mice and seemed to be using their insulin more efficiently."That is important to us because the majority of obese patients go on to develop Type 2 diabetes," Clapham said.
'"/>




Page: 1

Related medicine news :

1. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
2. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of ‘Huntingtons’ Disase
3. Unravelling the secrets of ‘Huntingtin’ Protein - towards the treatment of Huntingtins’ Disese
4. Protein in urine foresees heart disease
5. Levels Of Blood Proteins May Help Heart Disease Care
6. Protein signals need for heart surgery
7. Protein and fat improve memory
8. Clotting Protein plays a role in nerve repair
9. High Levels of Protein Linked to Brain Shrinkage
10. Protein can change worn muscle fibres
11. Protein in eye fights diseases
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... April 24, 2017 , ... ... seeking public support to bring their novel lifesaving device for the everyday use ... with medical-grade sensors, specially designed to read a child’s vital signs, and detect ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... are expected to be diagnosed globally; approximately 25,000 of them will be malignant.(1) ... greater use of this type of healthcare model in the diagnosis and treatment ...
(Date:4/24/2017)... ... April 24, 2017 , ... Come to PAINWeekEnd (PWE) Tampa on May 20 ... an educational and exciting 2-day program. , An attendee at a recent PAINWeekEnd ... approach patients” about the course entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Learning to Use Your SPIRITUAL COMPASS To Navigate ... Use Your SPIRITUAL COMPASS To Navigate Life Issues” is the creation of published author, ... the Board of Directors for CONTACT USA, and former member of the American Association ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... the development of next generation neuro-thrombectomy systems for the treatment of Acute Ischemic ... manufacture its ANCD BRAIN device as the product advances towards regulatory and clinical ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/18/2017)... April 18, 2017  Cardinal Health (NYSE: ... fiscal 2017 earnings per share (EPS) guidance and providing ... is in conjunction with this morning,s announcement of the ... and Nutritional Insufficiency businesses. Cardinal Health now ... will be at the bottom of its previous guidance ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, 2017 ... ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, and Cameron ... announced the signing of a three-year exclusive sales ... deploy a dedicated sales team to introduce Imprimis, ... primarily focused in 13 states in the U.S. ...
Breaking Medicine Technology: